Novo Nordisk (Ozempic)

6045.728 - 6080.858 David Rosenthal

That didn't happen here, which turns out to be, unbeknownst to pretty much anyone at the time, and I'm sure not even the foundation board, a very prescient decision to Because there is a small group of researchers within Novo Nordisk, led by a woman named Latte Bjerre Knudsen, who is working on a pretty incredible project that is showing a lot of promise. And that would be GLP-1 agonist drugs.